Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.

[1]  C. Fishwick,et al.  Analysis of Mupirocin Resistance and Fitness in Staphylococcus aureus by Molecular Genetic and Structural Modeling Techniques , 2004, Antimicrobial Agents and Chemotherapy.

[2]  D. Coşkun,et al.  Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment. , 2004, The Journal of hospital infection.

[3]  R. Engelman,et al.  Surgical site infections in cardiac surgery: an 11-year perspective. , 2004, American journal of infection control.

[4]  M. Wilcox,et al.  Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. , 2003, The Journal of hospital infection.

[5]  A. van Belkum,et al.  Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Wenzel,et al.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. , 2002, The New England journal of medicine.

[7]  J. Bargman,et al.  Emergence of Mupirocin-Resistant Staphylococcus Aureus in Chronic Peritoneal Dialysis Patients using Mupirocin Prophylaxis to Prevent Exit-Site Infection , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  R. Brown,et al.  Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. , 2001, Annals of Thoracic Surgery.

[9]  R. Auckenthaler,et al.  Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Charlett,et al.  Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. , 1998, The Journal of antimicrobial chemotherapy.

[11]  A. Le Coustumier,et al.  [Methicillin-resistant Staphylococcus aureus infection]. , 1997, Soins; la revue de reference infirmiere.

[12]  Mark A. Miller,et al.  Development of Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus After Widespread Use of Nasal Mupirocin Ointment , 1996, Infection Control & Hospital Epidemiology.

[13]  H. Verbrugh,et al.  Reduction of Surgical-Site Infections in Cardiothoracic Surgery by Elimination of Nasal Carriage of Staphylococcus aureus , 1996, Infection Control & Hospital Epidemiology.

[14]  A M HOOD,et al.  Phage typing of Staphylococcus aureus , 1953, Journal of Hygiene.

[15]  Z. Gulay,et al.  Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis. , 2004, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[16]  Y. Doki,et al.  Preoperative Intranasal Mupirocin Ointment Significantly Reduces Postoperative Infection with Staphylococcus aureus in Patients Undergoing Upper Gastrointestinal Surgery , 2000, Surgery Today.